OR HB2303 | 2019 | Regular Session

Status

Spectrum: Slight Partisan Bill (Democrat 8-5)
Status: Introduced on January 14 2019 - 25% progression
Action: 2019-03-26 - Work Session scheduled.
Pending: House Health Care Committee
Hearing: Mar 26 @ 3:00 pm in HR E
Text: Latest bill text (Introduced) [PDF]

Summary

Deletes requirement that pseudoephedrine be classified as Schedule III controlled substance. Directs State Board of Pharmacy to adopt rules for dispensing of pseudoephedrine. Requires rules to be consistent with provisions of federal Controlled Substances Act that are related to dispensing of pseudoephedrine and federal regulations that implement those provisions. Punishes violation of rules by five years' imprisonment, $125,000 fine, or both. Becomes operative January 1, 2020. Takes effect on 91st day following adjournment sine die.

Tracking Information

Register now for our free OneVote public service or GAITS Professional trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Relating to pseudoephedrine; prescribing an effective date.

Sponsors


History

DateChamberAction
2019-03-26HouseWork Session scheduled.
2019-03-07HousePublic Hearing held.
2019-01-18HouseReferred to Health Care.
2019-01-14HouseFirst reading. Referred to Speaker's desk.

Oregon State Sources


Bill Comments

feedback